Todd Holling was named CIO of Kootenai Health. Mr. Holling previously served as interim CIO for the Coeur d’Alene, Idaho-based health system since September 2025, according to a March 23 news release. Before joining Kootenai Health, he served as deputy…
The Latest
Three nurse practitioners are seeking to appeal a California judge’s ruling, which upheld state law restricting nonphysicians with doctorate degrees from calling themselves “doctor,” according to federal appeals court documents. After pushback from California officials, the NPs have until April…
Detroit-based Barbara Ann Karmanos Cancer Institute has become the first independent cancer center in the U.S. to provide a one-time gene therapy for the treatment of hemophilia B in adults. The first patient received the therapy — called Hemgenix —…
Phoenix-based Banner Health has appointed a longtime health system leader to serve as CEO of multiple facilities in Arizona. Dale Johns was named CEO of Banner Thunderbird Medical Center in Glendale, Banner Behavioral Health Hospital in Scottsdale and Banner MD…
SSM Health St. Mary’s Hospital in Jefferson City, Mo., has appointed Beth Eidson, MSN, chief nursing officer, effective March 22. Over the past decade, Ms. Eidson has served in leadership roles across multiple Missouri-based health systems, overseeing EHR implementations, level…
York, Pa.-based WellSpan Health is expanding its Medicare accountable care organization with the addition of Penn Highlands Healthcare, effective January 2027. Three things to know: 1. DuBois, Pa.-based Penn Highlands, which serves rural communities across western Pennsylvania, will join the…
Pfizer and Valneva’s investigational Lyme disease vaccine candidate, PF-07307405 (LB6V), demonstrated more than 70% efficacy in preventing Lyme disease among individuals age 5 and older, according to topline phase 3 trial results. The prespecified analysis showed 74.8% efficacy starting one…
Tyler Grajeda has been named vice president of operations for HCA Houston Healthcare Kingwood (Texas), according to a March 23 LinkedIn post. The hospital is part of Nashville, Tenn.-based HCA Healthcare’s HCA Houston Healthcare. Prior to his new role, Mr.…
Bristol Myers Squibb has received two expanded U.S. approvals for Opdivo (nivolumab) combinations that establish additional immunotherapy options for classical Hodgkin lymphoma across pediatric and adult populations. The FDA approved Opdivo in combination with doxorubicin, vinblastine and dacarbazine (AVD) for…
The Institute for Safe Medication Practices outlined 15 strategies for reducing medication errors in clinical settings in its 2026-2027 “Targeted Medication Safety Best Practices for Hospitals.” The update includes three new best practices and 12 carried forward from previous cycles.…